Richard D Minshall Selected Research

Interleukin-6 (Interleukin 6)

1/2023	Neutralization of excessive CCL28 improves wound healing in diabetic mice.
1/2020	CCL28-induced CCR10/eNOS interaction in angiogenesis and skin wound healing.
12/2019	Sevoflurane Promotes Bactericidal Properties of Macrophages through Enhanced Inducible Nitric Oxide Synthase Expression in Male Mice.
2/2012	Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Minshall Research Topics

Disease

20	Inflammation (Inflammations) 01/2023 - 04/2002
13	Sepsis (Septicemia) 01/2023 - 04/2002
10	Edema (Dropsy) 01/2022 - 11/2007
10	Lung Injury 01/2021 - 04/2005
8	Vascular Remodeling 01/2019 - 05/2008
7	Neoplasms (Cancer) 01/2022 - 02/2007
7	Pneumonia (Pneumonitis) 05/2015 - 02/2008
6	Ventilator-Induced Lung Injury 10/2021 - 08/2011
6	Pulmonary Hypertension 01/2021 - 05/2008
6	Acute Lung Injury 10/2020 - 04/2005
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 10/2019
5	Hypoxia (Hypoxemia) 10/2022 - 01/2015
4	Vascular System Injuries 01/2019 - 04/2002
4	Pulmonary Edema 01/2014 - 04/2005
3	Pulmonary Arterial Hypertension 10/2022 - 09/2010
3	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2007
3	Familial Primary Pulmonary Hypertension 05/2017 - 12/2013
2	Virus Diseases (Viral Diseases) 01/2024 - 08/2014
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2019
2	Dyslipidemias (Dyslipidemia) 10/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2012
2	Triple Negative Breast Neoplasms 01/2022 - 01/2022
2	Obesity 10/2020 - 11/2009
2	Vascular Diseases (Vascular Disease) 01/2019 - 01/2018
2	Fibrosis (Cirrhosis) 01/2012 - 12/2003
2	Lung Diseases (Lung Disease) 01/2012 - 09/2010
2	Ischemia 11/2007 - 04/2005
1	Cognitive Dysfunction 01/2024
1	Neuroinflammatory Diseases 01/2024
1	COVID-19 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Diabetic Foot 01/2023
1	Ulcer 01/2023
1	Hemolytic Anemia 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Insulin Resistance 10/2020

Drug/Important Bio-Agent (IBA)

23	Caveolin 1IBA 01/2024 - 12/2003
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
9	EndotoxinsIBA 10/2020 - 11/2007
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2016 - 04/2005
5	AlbuminsIBA 01/2024 - 01/2008
5	LipopolysaccharidesIBA 12/2019 - 01/2010
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2017 - 06/2011
5	Anesthetics (Anesthetic Agents)IBA 02/2015 - 04/2005
4	LipidsIBA 10/2023 - 11/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 02/2012
4	Peptides (Polypeptides)IBA 01/2020 - 05/2010
3	CytokinesIBA 12/2019 - 09/2015
3	Sevoflurane (Ultane)FDA LinkGeneric 12/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2015
3	Propofol (Diprivan)FDA LinkGeneric 02/2015 - 04/2005
2	Delta CateninIBA 01/2023 - 08/2011
2	InflammasomesIBA 01/2023 - 01/2019
2	Insulin (Novolin)FDA Link 01/2023 - 01/2016
2	oxidized low density lipoproteinIBA 10/2022 - 01/2018
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2022 - 01/2020
2	Potassium Channels (Potassium Channel)IBA 01/2022 - 01/2021
2	AntioxidantsIBA 01/2021 - 04/2005
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2017
2	Blood Proteins (Serum Proteins)IBA 10/2020 - 01/2008
2	Thrombin FDA Link 01/2020 - 10/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 09/2012
2	Oxidants (Oxidizing Agents)IBA 01/2018 - 09/2009
2	EnzymesIBA 01/2018 - 09/2010
2	Adenine FDA LinkGeneric 05/2017 - 03/2017
2	Vasoconstrictor AgentsIBA 01/2016 - 05/2008
2	Ropivacaine (Naropin)FDA LinkGeneric 01/2014 - 09/2012
2	Complementary DNA (cDNA)IBA 10/2012 - 04/2002
2	Liposomes (Liposome)IBA 10/2012 - 04/2002
1	Claudin-5IBA 01/2024
1	GlycosphingolipidsIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	CollagenIBA 10/2022
1	LigandsIBA 10/2022
1	OxidesIBA 10/2022
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2022
1	CC ChemokinesIBA 10/2022
1	1,3- bis(2- hydroxy- 5- trifluoromethylphenyl)ureaIBA 01/2022
1	GBT1118IBA 01/2022
1	ThrombomodulinIBA 01/2022
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	CateninsIBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021
1	cadherin 5IBA 01/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Leptin ReceptorsIBA 10/2020
1	Insulin-Like PeptidesIBA 10/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020

Therapy/Procedure

5	Therapeutics 01/2022 - 10/2014
4	Artificial Respiration (Mechanical Ventilation) 10/2021 - 02/2012
4	Punctures 01/2019 - 01/2013
4	Ligation 01/2019 - 01/2013
2	Resuscitation 02/2015 - 03/2009
1	Surgical Amputation (Amputations) 01/2023
1	Topical Administration 01/2020